Soo Bong Han

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 5 CIPO patents and 6 EPO patents. Top assignees: Korea Research Institute of Chemical Technology, Katholieke Universiteit Leuven, Novartis Ag. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soo Bong Han. Retrieved from https://idiyas.com/inventor/soo-bong-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Daejeon-si, KR (2017 - 2018)
Daejeon, KR (2016 - 2024)

Company Filing History:

9 out of 655

Korea Research Institute of Chemical Technology

patents

8 out of 631

Katholieke Universiteit Leuven

Kanaph Therapeutics Inc.

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760033 - Compounds having inhibitory activity on prostaglandin E2 receptor and uses thereof (2026-10-13),

2. 12286423 - Antiviral 1,3-di-oxo-indene compounds (2025-04-29),

3. 12083092 - Antiviral 1,3-di-oxo-indene compounds (2024-09-10),

4. 9951058 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2018-04-24),

5. 9890133 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2018-02-13),

6. 9833423 - 1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (2017-12-05),

7. 9790197 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2017-10-17),

8. 9464067 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2016-10-11),

9. 9346749 - 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (2016-05-24),

Title: The Innovations of Soo Bong Han

Introduction

Soo Bong Han is a prominent inventor based in Daejeon-si, South Korea. He has made significant contributions to the field of chemical technology, particularly in the development of antiviral compounds. With a total of eight patents to his name, Han's work has garnered attention in both academic and industrial circles.

Latest Patents

Among his latest innovations are the antiviral 1,3-di-oxo-indene compounds. These compounds, described in his patents, provide a novel approach to combating viral infections. The invention outlines compounds of Formula (I), showcasing their potential therapeutic applications.

Career Highlights

Soo Bong Han has had a distinguished career, working at notable institutions such as the Korea Research Institute of Chemical Technology and Katholieke Universiteit Leuven. His research has focused on advancing chemical technologies that can lead to significant health benefits.

Collaborations

Throughout his career, Han has collaborated with esteemed colleagues, including Hae Soo Kim and Johan Neyts. These partnerships have contributed to the success of his research and the development of innovative solutions in the field.

Conclusion

Soo Bong Han's contributions to the field of chemical technology and his innovative antiviral compounds highlight his role as a leading inventor. His work continues to influence research and development in the industry.

Profile summary based on public USPTO records.